Go Deep
Century Therapeutics, Inc.
Century Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,350 | -1.5 | 1.07 | 0.17 | 131.42 |
| Oct 2026 | 21,350 | -1.5 | 1.07 | 0.17 | 131.03 |
| Oct 2026 | 21,106 | -1.6 | 1.17 | 0.17 | 142.44 |
| Oct 2026 | 21,371 | -1.5 | 1.07 | 0.17 | 129.76 |
| Oct 2026 | 21,167 | -1.6 | 1.15 | 0.17 | 139.38 |
| Oct 2026 | 20,821 | -1.8 | 1.28 | 0.17 | 155.50 |
| Oct 2026 | 20,882 | -1.7 | 1.25 | 0.17 | 152.28 |
| Oct 2026 | 20,943 | -1.7 | 1.23 | 0.17 | 149.14 |
| Oct 2026 | 21,187 | -1.6 | 1.14 | 0.17 | 138.38 |
Century Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -34,550,000.0 | -21,645,000.0 | -19,171,000.0 | -34,422,000.0 |
| EPS | -0.2 | -0.1 | — | -0.4 |
Century Therapeutics, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 109,164,000.0 | 6,589,000.0 | 2,235,000.0 | 5,199,000.0 | — |
| Net Profit | -9,580,000.0 | -126,566,000.0 | -136,673,000.0 | -130,932,000.0 | — |
| EPS | -0.1 | -1.6 | -2.3 | -2.3 | — |
Century Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 223,704,000.0 | 353,216,000.0 | 360,691,000.0 | 486,544,000.0 | — |
| Total Liabilities | 64,768,000.0 | 191,854,000.0 | 175,941,000.0 | 183,806,000.0 | — |
| Total Equity | 158,936,000.0 | 161,362,000.0 | 184,750,000.0 | 302,738,000.0 | — |
Owes vs Owns
Century Therapeutics, Inc. owed $0.19 for every $1 it owned in Jun 2026, down from $0.38 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.19× | 0.29× | 0.54× | 0.49× | 0.38× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Century Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 52.4%Fixed assets (tangible) 29.6%Intangible assets 15.3%Other assets 2.5%
How it's funded — Dec 2025
Short-term debt 1.5%Long-term debt 18.0%Payables 2.1%Other liabilities 7.3%Shareholders' equity 71.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 117.1 | 189.3 | 172.7 | 315.5 |
| Receivables | 0.7 | 1.5 | 2.2 | 0.8 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 66.2 | 90.8 | 92.1 | 111.7 |
| Intangible assets | 34.2 | 34.2 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 30.8 | 89.1 | 51.9 |
| Other assets | 5.6 | 6.5 | 4.5 | 6.7 |
| Liabilities & equity | ||||
| Short-term debt | 3.3 | 4.9 | 1.5 | 6.5 |
| Long-term debt | 40.2 | 49.0 | 46.7 | 3.7 |
| Payables | 4.8 | 3.1 | 2.7 | 5.5 |
| Other liabilities | 16.4 | 134.9 | 125.0 | 168.1 |
| Shareholders' equity | 158.9 | 161.4 | 184.8 | 302.7 |
| Net tangible assets | 124.7 | 127.2 | 184.8 | 302.7 |
Century Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -103,876,000.0 | -110,135,000.0 | -88,348,000.0 | 14,052,000.0 | — |
| Investing Activities | 107,501,000.0 | 47,482,000.0 | 61,132,000.0 | -13,128,000.0 | — |
| Financing Activities | 173,000.0 | 74,563,000.0 | -9,725,000.0 | 27,158,000.0 | — |